Last updated: January 26, 2020
Sponsor: Al-Neelain University
Overall Status: Active - Recruiting
Phase
2/3
Condition
Anemia
Treatment
N/AClinical Study ID
NCT04191213
GA& Sickle among children
Ages 3-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Homozygous for Sickle Cell Disease (SS) as documented by Haemoglobin electrophoresis. Subjects whom medications and dosages had been stable for 2 weeks before study entry. Subjects who have not received blood transfusion or had acute episode related to sicklecell disease in the last two weeks before the start of intervention.
Exclusion
Exclusion Criteria:
- Patients with history of Gum Arabic allergy. Patients who have ischemic heart disease,liver dysfunction or hepatitis. Pregnant female patients who plan to conceive in thenext 4 months and fertile female patients who are not using an effective contraceptionmethod. Patients who are currently using Gum Arabic. Patients who are on steroids or chemotherapy.
Study Design
Total Participants: 100
Study Start date:
February 15, 2020
Estimated Completion Date:
July 15, 2020
Study Description
Connect with a study center
Military Hospital
Omdurman, Khartoum 1113
SudanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.